{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:31:40Z","timestamp":1794339100912,"version":"4.9.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lipoprotein glomerulopathy (LPG) is a apolipoprotein E (ApoE)-related glomerular disease and has been associated with type III hyperlipidemia. Without appropriate treatment, chronic kidney disease (CKD) caused by LPG progresses, and approximately half of the patients develop end-stage kidney disease within 1\u201327\u00a0years of disease onset. However, few studies have highlighted the clinical course of cardiovascular diseases (CVDs) in patients with LPG. Herein, we report the first case of LPG in which the CVD risk was assessed using arterial stiffness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 32-year-old Japanese man was referred to our hospital due to persistent proteinuria. Kidney biopsy showed markedly dilated capillary lumens containing pale-stained thrombi, which stained positively with Oil Red O. Electron microscopy revealed the presence of thrombi in the capillary lumen with low electron density and vacuoles of various sizes in part of the thrombi. Toluidine blue and Sudan IV stains were used to stain the thin sections of Epon-embedded tissue samples for electron microscopy. Sudan IV-positive droplets were observed in the capillary lumens, vascular walls, and cytoplasm of tubular cells. Increased serum ApoE concentration was observed. Liquid chromatography-tandem mass spectrometry of laser-microdissected glomeruli from paraffin sections revealed an increase in ApoE. Direct deoxyribonucleic acid sequencing of ApoE revealed a heterozygous ApoE Sendai mutation (Arg145Pro). The patient was finally diagnosed with LPG with heterozygosity for ApoE-Sendai mutation (Arg145Pro). Notably, at the time of diagnosis, he had markedly increased arterial stiffness for his age. Arterial stiffness was measured using brachial-ankle pulse wave velocity (baPWV), which was equivalent to that of a 56-year-old man. After three months of treatment with fenofibrate and losartan, a significant reduction in proteinuria was achieved along with an improvement in baPWV. Furthermore, these effects were maintained despite the lack of decrease in serum ApoE levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Herein, we report the case of a patient with LPG with markedly increased arterial stiffness at the time of diagnosis, in whom combination therapy with fenofibrate and losartan successfully improved proteinuria and arterial stiffness. To the best of our knowledge, this is the first case report of LPG in which CVD risk was assessed using arterial stiffness.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-024-03612-z","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T13:01:43Z","timestamp":1716210103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Junichiro","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Okonogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Kanzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sagasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Komine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh","family":"Tokutou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuho","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,20]]},"reference":[{"issue":"2","key":"3612_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0272-6386(89)80134-9","volume":"13","author":"T Saito","year":"1989","unstructured":"Saito T, Sato H, Kudo K, Oikawa S, Shibata T, Hara Y, et al. Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am J Kidney Dis. 1989;13(2):148\u201353.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"3612_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1053\/j.ajkd.2005.10.017","volume":"47","author":"T Saito","year":"2006","unstructured":"Saito T, Matsunaga A, Oikawa S. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis. 2006;47(2):199\u2013211.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"3612_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.kint.2019.10.031","volume":"97","author":"T Saito","year":"2020","unstructured":"Saito T, Matsunaga A, Fukunaga M, Nagahama K, Hara S, Muso E. Apolipoprotein E-related glomerular disorders. Kidney Int. 2020;97(2):279\u201388.","journal-title":"Kidney Int"},{"issue":"2","key":"3612_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s10157-013-0887-4","volume":"18","author":"T Saito","year":"2014","unstructured":"Saito T, Matsunaga A, Ito K, Nakashima H. Topics in lipoprotein glomerulopathy: an overview. Clin Exp Nephrol. 2014;18(2):214\u20137.","journal-title":"Clin Exp Nephrol"},{"key":"3612_CR5","doi-asserted-by":"publisher","first-page":"905007","DOI":"10.3389\/fmed.2022.905007","volume":"9","author":"M Li","year":"2022","unstructured":"Li M, Li Y, Liu Y, Zhou X, Zhang H. An updated review and meta analysis of lipoprotein glomerulopathy. Front Med. 2022;9:905007. https:\/\/doi.org\/10.3389\/fmed.2022.905007.","journal-title":"Front Med"},{"issue":"10","key":"3612_CR6","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1093\/ndt\/gfs329","volume":"27","author":"K Ito","year":"2012","unstructured":"Ito K, Nakashima H, Watanabe M, Ishimura A, Miyahara Y, Abe Y, et al. Macrophage impairment produced by Fc receptor gamma deficiency plays a principal role in the development of lipoprotein glomerulopathy in concert with apoE abnormalities. Nephrol Dial Transplant. 2012;27(10):3899\u2013907.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"3612_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","volume":"19","author":"A Mitrofanova","year":"2023","unstructured":"Mitrofanova A, Merscher S, Fornoni A. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat Rev Nephrol. 2023;19(10):629\u201345.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"3612_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.4093\/dmj.2023.0067","volume":"47","author":"SH Suh","year":"2023","unstructured":"Suh SH, Kim SW. Dyslipidemia in patients with chronic kidney disease: An updated overview. Diabetes Metab J. 2023;47(5):612\u201329.","journal-title":"Diabetes Metab J"},{"issue":"7","key":"3612_CR9","doi-asserted-by":"publisher","first-page":"621","DOI":"10.5551\/jat.RV17041","volume":"27","author":"H Tomiyama","year":"2020","unstructured":"Tomiyama H, Shiina K. State of the art review: brachial-ankle PWV. J Atheroscler Thromb. 2020;27(7):621\u201336.","journal-title":"J Atheroscler Thromb"},{"issue":"8","key":"3612_CR10","doi-asserted-by":"publisher","first-page":"732","DOI":"10.5551\/jat.RV17043","volume":"27","author":"A Saiki","year":"2020","unstructured":"Saiki A, Ohira M, Yamaguchi T, Nagayama D, Shimizu N, Shirai K, et al. New horizons of arterial stiffness developed using Cardio-Ankle Vascular Index (CAVI). J Atheroscler Thromb. 2020;27(8):732\u201348.","journal-title":"J Atheroscler Thromb"},{"issue":"5","key":"3612_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10157-001-8020-5","volume":"13","author":"S Mochizuki","year":"2001","unstructured":"Mochizuki S, Moriya T, Naganuma H, Narasaka T, Ueno Y, Sato H, et al. Significance of fat stains in serial sections from Epon-embedded tissue samples for electron microscopy in renal diseases. Clin Exp Nephrol. 2001;13(5):240\u20135.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"3612_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000441715","volume":"5","author":"S Takasaki","year":"2015","unstructured":"Takasaki S, Maeda K, Joh K, Yamakage S, Fukase S, Takahashi T, et al. Macrophage infiltration into the glomeruli in lipoprotein glomerulopathy. Case Rep Nephrol Dial. 2015;5(3):204\u201312.","journal-title":"Case Rep Nephrol Dial"},{"issue":"4","key":"3612_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/nep.13676","volume":"25","author":"N Kawata","year":"2020","unstructured":"Kawata N, Kang D, Aiuchi T, Obama T, Yoshitake O, Shibata T, et al. Proteomics of human glomerulonephritis by laser microdissection and liquid chromatography-tandem mass spectrometry. Nephrology. 2020;25(4):351\u20139.","journal-title":"Nephrology"},{"issue":"1","key":"3612_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1053\/ajkd.2003.50016","volume":"41","author":"N Ieiri","year":"2003","unstructured":"Ieiri N, Hotta O, Taguma Y. Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy. Am J Kidney Dis. 2003;41(1):244\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"3612_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0021-9150(03)00194-1","volume":"169","author":"T Arai","year":"2003","unstructured":"Arai T, Yamashita S, Yamane M, Manabe N, Matsuzaki T, Kuriyama K, et al. Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy. Atherosclerosis. 2003;169(2):293\u20139.","journal-title":"Atherosclerosis"},{"issue":"2","key":"3612_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/ndt\/gfm675","volume":"23","author":"M Kinomura","year":"2008","unstructured":"Kinomura M, Sugiyama H, Saito T, Matsunaga A, Sada K, Kanazaki M, et al. A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy. Nephrol Dial Transplant. 2008;23(2):751\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"15","key":"3612_CR17","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.2169\/internalmedicine.0834-22","volume":"62","author":"H Tanimizu","year":"2023","unstructured":"Tanimizu H, Hara R, Sekine A, Inoue N, Hasegawa E, Tanaka K, et al. Apolipoprotein E-associated lipoprotein glomerulo-tubulopathy. Int Med. 2023;62(15):2209\u201314.","journal-title":"Int Med"},{"key":"3612_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.atherosclerosis.2016.03.035","volume":"249","author":"M Kajikawa","year":"2016","unstructured":"Kajikawa M, Maruhashi T, Matsumoto T, Iwamoto Y, Iwamoto A, Oda N, et al. Relationship between serum triglyceride levels and endothelial function in a large community-based study. Atherosclerosis. 2016;249:70\u20135. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.03.035.","journal-title":"Atherosclerosis"},{"issue":"2","key":"3612_CR19","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1016\/j.atherosclerosis.2006.11.007","volume":"194","author":"KE Ryan","year":"2007","unstructured":"Ryan KE, McCance DR, Powell L, McMahon R, Trimble ER. Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men. Atherosclerosis. 2007;194(2):e123\u201330. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.11.007.","journal-title":"Atherosclerosis"},{"issue":"11","key":"3612_CR20","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","volume":"298","author":"AM Bennet","year":"2007","unstructured":"Bennet AM, Angelantonio ED, Ye Z, Wensley F, Dahlin A, Ahlbom A, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 2007;298(11):1300\u201311.","journal-title":"JAMA"},{"issue":"21","key":"3612_CR21","doi-asserted-by":"publisher","first-page":"12947","DOI":"10.3390\/ijms232112947","volume":"23","author":"M Civeira-Marin","year":"2022","unstructured":"Civeira-Marin M, Cenarro A, Marco-Benedi V, Bea AM, Mateo-Gallego R, Moreno-Franco B, et al. APOE genotypes modulate inflammation independently of their effect on lipid metabolism. Int J Mol Sci. 2022;23(21):12947. https:\/\/doi.org\/10.3390\/ijms232112947.","journal-title":"Int J Mol Sci"},{"key":"3612_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2016.10.037","volume":"255","author":"KL Rasmussen","year":"2016","unstructured":"Rasmussen KL. Plasma levels of apolipoprotein E, APOE genotypes and risk of dementia and ischemic heart disease: A review. Atherosclerosis. 2016;255:145\u201355. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.10.037.","journal-title":"Atherosclerosis"},{"issue":"3","key":"3612_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.humimm.2010.01.008","volume":"71","author":"JA Hubacek","year":"2010","unstructured":"Hubacek JA, Peasey A, Pikhart H, Stavek P, Kubinova R, Marmot M, et al. ApoE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample. Human Immunol. 2010;71(3):304\u20138.","journal-title":"Human Immunol"},{"issue":"1","key":"3612_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.atherosclerosis.2012.04.021","volume":"223","author":"Z Gungor","year":"2012","unstructured":"Gungor Z, Anuurad E, Enkhmaa B, Zhang W, Kim K, Berglund L. Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk. Atherosclerosis. 2012;223(1):230\u20134. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.04.021.","journal-title":"Atherosclerosis"},{"issue":"12","key":"3612_CR25","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.jacc.2006.08.032","volume":"48","author":"DN Tziakas","year":"2006","unstructured":"Tziakas DN, Chalikias GK, Antonoglou CO, Veletza S, Tentes IK, Kortsaris AX, et al. Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease. J Am Coll Cardiol. 2006;48(12):2471\u201381.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03612-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03612-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03612-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T13:03:30Z","timestamp":1716210210000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03612-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3612"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03612-z","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,20]]},"assertion":[{"value":"25 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The need for approval was waived by the Ethics Committee of Atsugi City Hospital as this was a retrospective case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent participate"}},{"value":"Written informed consent was obtained from the patient for analysis of the phenotype, genotype, and DNA sequence of ApoE, and for publication of clinical information, including symptoms, laboratory data, histological findings, and any accompanying images as a case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}